UnitedHealth Group Incorporated $UNH Stake Boosted by Wealth Architects LLC

Wealth Architects LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,987 shares of the healthcare conglomerate’s stock after buying an additional 205 shares during the quarter. Wealth Architects LLC’s holdings in UnitedHealth Group were worth $1,868,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Nabity Jensen Investment Management Inc raised its stake in shares of UnitedHealth Group by 0.9% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its position in UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 25 shares in the last quarter. Stewardship Advisors LLC boosted its holdings in UnitedHealth Group by 4.1% during the first quarter. Stewardship Advisors LLC now owns 663 shares of the healthcare conglomerate’s stock valued at $347,000 after purchasing an additional 26 shares in the last quarter. Osborne Partners Capital Management LLC raised its holdings in shares of UnitedHealth Group by 2.5% in the 1st quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock worth $558,000 after buying an additional 26 shares in the last quarter. Finally, HHM Wealth Advisors LLC boosted its stake in UnitedHealth Group by 0.9% in the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.6%

NYSE UNH opened at $354.30 on Monday. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a price-to-earnings-growth ratio of 2.29 and a beta of 0.47. The stock has a fifty day moving average of $318.21 and a 200-day moving average of $348.08.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Barclays boosted their price target on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. KeyCorp raised their price target on UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.